Application Research of Methylation Markers in Early-stage Lung Cancer Patients Treated With Co-ablation System Therapy
Conditions
Lung Cancer (NSCLC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Haidian Hospital, Beijing, Beijing Municipality, China
Study leads
Yuqing Huang
Principal Investigator
Beijing Haidian Hospital